Analysts Set BWX Technologies, Inc. (NYSE:BWXT) Price Target at $199.20

Shares of BWX Technologies, Inc. (NYSE:BWXT) have earned an average rating of “Moderate Buy” from the thirteen research firms that are presently covering the stock, MarketBeat.com reports. Five research analysts have rated the stock with a hold rating, five have given a buy rating and three have assigned a strong buy rating to the company. The average 1-year target price among brokerages that have issued a report on the stock in the last year is $199.20.

BWXT has been the subject of a number of recent analyst reports. CJS Securities upgraded BWX Technologies to a “strong-buy” rating in a research report on Friday, December 12th. Northland Securities set a $225.00 price objective on BWX Technologies in a research report on Tuesday, November 4th. Weiss Ratings downgraded BWX Technologies from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, January 26th. Wall Street Zen upgraded BWX Technologies from a “hold” rating to a “buy” rating in a report on Saturday, November 8th. Finally, BNP Paribas Exane started coverage on BWX Technologies in a research note on Thursday, January 15th. They issued a “neutral” rating and a $215.00 price objective for the company.

BWX Technologies Trading Down 1.3%

Shares of BWXT stock opened at $206.35 on Friday. The stock has a market cap of $18.87 billion, a P/E ratio of 61.97, a price-to-earnings-growth ratio of 3.36 and a beta of 0.84. BWX Technologies has a 1 year low of $84.21 and a 1 year high of $220.57. The company has a current ratio of 1.71, a quick ratio of 1.62 and a debt-to-equity ratio of 1.21. The stock has a 50 day simple moving average of $195.15 and a 200 day simple moving average of $186.56.

Insider Activity

In other news, CEO Rex D. Geveden sold 10,000 shares of BWX Technologies stock in a transaction on Thursday, February 12th. The shares were sold at an average price of $203.26, for a total transaction of $2,032,600.00. Following the transaction, the chief executive officer owned 177,594 shares in the company, valued at approximately $36,097,756.44. The trade was a 5.33% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.47% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the stock. ARK Investment Management LLC lifted its holdings in BWX Technologies by 426.5% in the second quarter. ARK Investment Management LLC now owns 641,049 shares of the technology company’s stock valued at $92,350,000 after buying an additional 519,285 shares during the period. Massachusetts Financial Services Co. MA boosted its position in shares of BWX Technologies by 26.0% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 1,159,033 shares of the technology company’s stock valued at $213,691,000 after purchasing an additional 239,292 shares in the last quarter. Eos Management L.P. grew its stake in BWX Technologies by 27.9% during the third quarter. Eos Management L.P. now owns 25,894 shares of the technology company’s stock worth $4,774,000 after purchasing an additional 5,644 shares during the period. Principal Financial Group Inc. increased its holdings in BWX Technologies by 51.1% in the third quarter. Principal Financial Group Inc. now owns 313,192 shares of the technology company’s stock worth $57,743,000 after purchasing an additional 105,879 shares in the last quarter. Finally, Police & Firemen s Retirement System of New Jersey lifted its stake in BWX Technologies by 4.7% in the second quarter. Police & Firemen s Retirement System of New Jersey now owns 34,636 shares of the technology company’s stock valued at $4,990,000 after buying an additional 1,548 shares during the period. 94.39% of the stock is owned by institutional investors.

BWX Technologies Company Profile

BWX Technologies, Inc (NYSE: BWXT) is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company’s core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non‐defense power generation, offering scalable solutions to meet evolving energy and industrial demands.

Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.